The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session

Saxagliptin is a potent, selective DPP4 inhibitor. Highlights from abstracts presented at the 2010 meetings of the European Association for the Study of Diabetes and the American Diabetes Association include studies and analyses that shed light on the promising role for saxagliptin within the manage...

Descripción completa

Detalles Bibliográficos
Autor principal: Aschner, Pablo J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020162/
https://www.ncbi.nlm.nih.gov/pubmed/21159194
http://dx.doi.org/10.1186/1758-5996-2-69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020162/
https://www.ncbi.nlm.nih.gov/pubmed/21159194
http://dx.doi.org/10.1186/1758-5996-2-69

Ejemplares similares